There is no hair-relaxer settlement fund or payout schedule yet. Eligibility today means qualifying for attorney review in the pending federal litigation, generally with regular long-term relaxer use and a later diagnosis of uterine, endometrial or ovarian cancer, or fibroids requiring hysterectomy.
A hair-relaxer lawsuit is an individual injury claim linking chemical straighteners to those diagnoses. The federal cases are coordinated as MDL No. 3060, a central pretrial process for related federal claims, not a class-action claims program.
Official resources:
- Read the official guidance from Reginfo — Use this primary source to verify the official guidance.
- Read the official notice from Lawsuit Information Center — Use this primary source to verify the official announcement.
Table of Contents
- Where the federal cases stand
- Who may qualify for attorney review
- What the cancer-risk study found
- What future payouts would depend on
Where the federal cases stand
The cases sit before Judge Mary Rowland in the Northern District of Illinois. They are in expert discovery and bellwether preparation, not in a settlement-claims phase.
According to the Miller & Zois Lawsuit Information Center update, 12,381 federal cases were still pending and no plaintiff had received an MDL payout as of October 2026 (Miller & Zois case update). The court narrowed the first bellwether pool to five cancer cases, with the first federal trial set for Sept. 7, 2027, according to an AboutLawsuits report (AboutLawsuits bellwether report).
Who may qualify for attorney review
Attorneys generally look for regular, long-term use of chemical relaxers or straighteners, followed by uterine or endometrial cancer, ovarian cancer, or severe fibroids treated with hysterectomy. Occasional use, short-term use, or a diagnosis outside those categories is less likely to meet screening criteria. Useful records include: Strong cases pair a clear product history with medical proof.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
- Product names, dates and place of use, and salon or home-use history
- Medical records showing diagnosis, pathology, surgery and treatment dates
- Proof of purchase, photos of products, or witness statements when receipts are gone
What the cancer-risk study found
The key study is the NIH Sister Study of 33,497 U.S. women ages 35-74.
It linked frequent straightener use to more than double the uterine-cancer risk, with about 4% developing cancer by age 70 versus 1.64% among nonusers, according to the National Institutes of Health news release (National Institutes of Health news release). The association was similar by race, but NIH said effects may be greater for Black women because about 60% of frequent users were Black women who use products more often and from earlier ages. The same study found no uterine-cancer link for dyes, bleach, highlights or perms, pointing specifically at straighteners.
What future payouts would depend on
Published ranges such as $100,000 to $1.5 million are law-firm estimates drawn from other mass torts. They are not negotiated tiers and do not promise what any hair-relaxer case will pay.
Later compensation would likely turn on cancer type and severity, age at diagnosis, treatment and surgery, lost income and medical cost, and strength of product-use proof. FDA action remains only a proposed rule that would prohibit formaldehyde and formaldehyde-releasing chemicals in heated smoothing products, with no final ban enacted. Keep product lists and medical files current before contacting a firm.
You Might Also Like
- Roundup Lawsuit October 2026 Settlement Update Explained
- Monsanto Roundup Lawsuit Settlement Payouts Explained
- Spinal Cord Stimulator Lawsuit Settlements Explained for MDL Claims